MedPath
NMPA Approval

Thymopolypeptides Injection

国药准字H23020851

March 20, 2021

国药准字H23020851

Drug Information

胸腺肽注射液

注射剂

2ml:20mg

化学药品

March 20, 2021

Company Information

Applicant Company

黑龙江省绥化市安达市北四道街(北四路)

Manufacturing Company

黑龙江省绥化市安达市北四道街(北四路)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

胸腺肽注射液 - NMPA 批准文号 | MedPath